Metabolomics implicate eicosanoids in severe functional mitral regurgitation

AIMS: Secondary, or functional, mitral regurgitation (FMR) was recently recognized as a separate clinical entity, complicating heart failure with reduced ejection fraction (HFrEF) and entailing particularly poor outcome. Currently, there is a lack of targeted therapies for FMR due to the fact that p...

Descripción completa

Detalles Bibliográficos
Autores principales: Hofbauer, Thomas M., Distelmaier, Klaus, Muqaku, Besnik, Spinka, Georg, Seidl, Veronika, Arfsten, Henrike T., Hagn, Gerhard, Meier‐Menches, Samuel, Bartko, Philipp E., Pavo, Noemi, Hoke, Matthias, Prausmueller, Suriya, Heitzinger, Gregor, Pils, Dietmar, Lang, Irene M., Hengstenberg, Christian, Hülsmann, Martin P., Gerner, Christopher, Goliasch, Georg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871691/
https://www.ncbi.nlm.nih.gov/pubmed/36217578
http://dx.doi.org/10.1002/ehf2.14160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871691/
https://www.ncbi.nlm.nih.gov/pubmed/36217578
http://dx.doi.org/10.1002/ehf2.14160

Ejemplares similares